Literature DB >> 22991473

Identification of a specific reprogramming-associated epigenetic signature in human induced pluripotent stem cells.

Sergio Ruiz1, Dinh Diep, Athurva Gore, Athanasia D Panopoulos, Nuria Montserrat, Nongluk Plongthongkum, Sachin Kumar, Ho-Lim Fung, Alessandra Giorgetti, Josipa Bilic, Erika M Batchelder, Holm Zaehres, Natalia G Kan, Hans Robert Schöler, Mark Mercola, Kun Zhang, Juan Carlos Izpisua Belmonte.   

Abstract

Generation of human induced pluripotent stem cells (hiPSCs) by the expression of specific transcription factors depends on successful epigenetic reprogramming to a pluripotent state. Although hiPSCs and human embryonic stem cells (hESCs) display a similar epigenome, recent reports demonstrated the persistence of specific epigenetic marks from the somatic cell type of origin and aberrant methylation patterns in hiPSCs. However, it remains unknown whether the use of different somatic cell sources, encompassing variable levels of selection pressure during reprogramming, influences the level of epigenetic aberrations in hiPSCs. In this work, we characterized the epigenomic integrity of 17 hiPSC lines derived from six different cell types with varied reprogramming efficiencies. We demonstrate that epigenetic aberrations are a general feature of the hiPSC state and are independent of the somatic cell source. Interestingly, we observe that the reprogramming efficiency of somatic cell lines inversely correlates with the amount of methylation change needed to acquire pluripotency. Additionally, we determine that both shared and line-specific epigenetic aberrations in hiPSCs can directly translate into changes in gene expression in both the pluripotent and differentiated states. Significantly, our analysis of different hiPSC lines from multiple cell types of origin allow us to identify a reprogramming-specific epigenetic signature comprised of nine aberrantly methylated genes that is able to segregate hESC and hiPSC lines regardless of the somatic cell source or differentiation state.

Entities:  

Mesh:

Year:  2012        PMID: 22991473      PMCID: PMC3479609          DOI: 10.1073/pnas.1202352109

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  35 in total

1.  Generation of human induced pluripotent stem cells from dermal fibroblasts.

Authors:  W E Lowry; L Richter; R Yachechko; A D Pyle; J Tchieu; R Sridharan; A T Clark; K Plath
Journal:  Proc Natl Acad Sci U S A       Date:  2008-02-15       Impact factor: 11.205

2.  Reprogramming of human somatic cells to pluripotency with defined factors.

Authors:  In-Hyun Park; Rui Zhao; Jason A West; Akiko Yabuuchi; Hongguang Huo; Tan A Ince; Paul H Lerou; M William Lensch; George Q Daley
Journal:  Nature       Date:  2007-12-23       Impact factor: 49.962

3.  Induced pluripotent stem cell lines derived from human somatic cells.

Authors:  Junying Yu; Maxim A Vodyanik; Kim Smuga-Otto; Jessica Antosiewicz-Bourget; Jennifer L Frane; Shulan Tian; Jeff Nie; Gudrun A Jonsdottir; Victor Ruotti; Ron Stewart; Igor I Slukvin; James A Thomson
Journal:  Science       Date:  2007-11-20       Impact factor: 47.728

4.  Induction of pluripotent stem cells from adult human fibroblasts by defined factors.

Authors:  Kazutoshi Takahashi; Koji Tanabe; Mari Ohnuki; Megumi Narita; Tomoko Ichisaka; Kiichiro Tomoda; Shinya Yamanaka
Journal:  Cell       Date:  2007-11-30       Impact factor: 41.582

5.  Direct reprogramming of genetically unmodified fibroblasts into pluripotent stem cells.

Authors:  Alexander Meissner; Marius Wernig; Rudolf Jaenisch
Journal:  Nat Biotechnol       Date:  2007-08-27       Impact factor: 54.908

6.  Targeted bisulfite sequencing reveals changes in DNA methylation associated with nuclear reprogramming.

Authors:  Jie Deng; Robert Shoemaker; Bin Xie; Athurva Gore; Emily M LeProust; Jessica Antosiewicz-Bourget; Dieter Egli; Nimet Maherali; In-Hyun Park; Junying Yu; George Q Daley; Kevin Eggan; Konrad Hochedlinger; James Thomson; Wei Wang; Yuan Gao; Kun Zhang
Journal:  Nat Biotechnol       Date:  2009-03-29       Impact factor: 54.908

7.  Efficient and rapid generation of induced pluripotent stem cells from human keratinocytes.

Authors:  Trond Aasen; Angel Raya; Maria J Barrero; Elena Garreta; Antonella Consiglio; Federico Gonzalez; Rita Vassena; Josipa Bilić; Vladimir Pekarik; Gustavo Tiscornia; Michael Edel; Stéphanie Boué; Juan Carlos Izpisúa Belmonte
Journal:  Nat Biotechnol       Date:  2008-10-17       Impact factor: 54.908

8.  Recurrent variations in DNA methylation in human pluripotent stem cells and their differentiated derivatives.

Authors:  Kristopher L Nazor; Gulsah Altun; Candace Lynch; Ha Tran; Julie V Harness; Ileana Slavin; Ibon Garitaonandia; Franz-Josef Müller; Yu-Chieh Wang; Francesca S Boscolo; Eyitayo Fakunle; Biljana Dumevska; Sunray Lee; Hyun Sook Park; Tsaiwei Olee; Darryl D D'Lima; Ruslan Semechkin; Mana M Parast; Vasiliy Galat; Andrew L Laslett; Uli Schmidt; Hans S Keirstead; Jeanne F Loring; Louise C Laurent
Journal:  Cell Stem Cell       Date:  2012-05-04       Impact factor: 24.633

9.  Library-free methylation sequencing with bisulfite padlock probes.

Authors:  Dinh Diep; Nongluk Plongthongkum; Athurva Gore; Ho-Lim Fung; Robert Shoemaker; Kun Zhang
Journal:  Nat Methods       Date:  2012-02-05       Impact factor: 28.547

10.  The human colon cancer methylome shows similar hypo- and hypermethylation at conserved tissue-specific CpG island shores.

Authors:  Rafael A Irizarry; Christine Ladd-Acosta; Andrew P Feinberg; Bo Wen; Zhijin Wu; Carolina Montano; Patrick Onyango; Hengmi Cui; Kevin Gabo; Michael Rongione; Maree Webster; Hong Ji; James Potash; Sarven Sabunciyan
Journal:  Nat Genet       Date:  2009-01-18       Impact factor: 38.330

View more
  83 in total

Review 1.  The Nexus of Stem Cell-Derived Beta-Cells and Genome Engineering.

Authors:  Sara D Sackett; Aida Rodriguez; Jon S Odorico
Journal:  Rev Diabet Stud       Date:  2017-06-12

Review 2.  Advances in the profiling of DNA modifications: cytosine methylation and beyond.

Authors:  Nongluk Plongthongkum; Dinh H Diep; Kun Zhang
Journal:  Nat Rev Genet       Date:  2014-08-27       Impact factor: 53.242

Review 3.  Preclinical studies for induced pluripotent stem cell-based therapeutics.

Authors:  John Harding; Oleg Mirochnitchenko
Journal:  J Biol Chem       Date:  2013-12-20       Impact factor: 5.157

Review 4.  Toward pluripotency by reprogramming: mechanisms and application.

Authors:  Tao Wang; Stephen T Warren; Peng Jin
Journal:  Protein Cell       Date:  2013-11       Impact factor: 14.870

5.  Differentiation-defective phenotypes revealed by large-scale analyses of human pluripotent stem cells.

Authors:  Michiyo Koyanagi-Aoi; Mari Ohnuki; Kazutoshi Takahashi; Keisuke Okita; Hisashi Noma; Yuka Sawamura; Ito Teramoto; Megumi Narita; Yoshiko Sato; Tomoko Ichisaka; Naoki Amano; Akira Watanabe; Asuka Morizane; Yasuhiro Yamada; Tosiya Sato; Jun Takahashi; Shinya Yamanaka
Journal:  Proc Natl Acad Sci U S A       Date:  2013-11-20       Impact factor: 11.205

6.  The silver lining of induced pluripotent stem cell variation.

Authors:  Valentina Fossati; Tanya Jain; Ana Sevilla
Journal:  Stem Cell Investig       Date:  2016-12-06

7.  Tankyrase inhibition promotes a stable human naïve pluripotent state with improved functionality.

Authors:  Ludovic Zimmerlin; Tea Soon Park; Jeffrey S Huo; Karan Verma; Sarshan R Pather; C Conover Talbot; Jasmin Agarwal; Diana Steppan; Yang W Zhang; Michael Considine; Hong Guo; Xiufeng Zhong; Christian Gutierrez; Leslie Cope; M Valeria Canto-Soler; Alan D Friedman; Stephen B Baylin; Elias T Zambidis
Journal:  Development       Date:  2016-09-22       Impact factor: 6.868

8.  Human oocytes reprogram adult somatic nuclei of a type 1 diabetic to diploid pluripotent stem cells.

Authors:  Mitsutoshi Yamada; Bjarki Johannesson; Ido Sagi; Lisa Cole Burnett; Daniel H Kort; Robert W Prosser; Daniel Paull; Michael W Nestor; Matthew Freeby; Ellen Greenberg; Robin S Goland; Rudolph L Leibel; Susan L Solomon; Nissim Benvenisty; Mark V Sauer; Dieter Egli
Journal:  Nature       Date:  2014-04-28       Impact factor: 49.962

Review 9.  Translating induced pluripotent stem cells from bench to bedside: application to retinal diseases.

Authors:  Alona O Cramer; Robert E MacLaren
Journal:  Curr Gene Ther       Date:  2013-04       Impact factor: 4.391

Review 10.  Current status in cancer cell reprogramming and its clinical implications.

Authors:  Kenan Izgi; Halit Canatan; Banu Iskender
Journal:  J Cancer Res Clin Oncol       Date:  2016-09-12       Impact factor: 4.553

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.